News
Pharmac will fund a new type of insulin for people with diabetes, branded as Ryzodeg, from May 1 2025. Pharmac’s Director ...
Over half of all dogs in the United States today are overweight or obese, placing them at increased risk for chronic diseases ...
Commonly used along with long-acting insulin. Rapid-acting 15 min 1 hour 2 to 4 hours Taken with meals, typically right before a meal. Commonly used along with longer-acting insulin. Rapid-acting ...
Sanofi India is divesting its insulin brand, Lantus, with Glenmark, Dr. Reddy's, and Emcure Pharma considering acquisition, though a licensing agreement remains a possibility. The asking price has ...
During summer, high temperatures can compromise the effectiveness of medications for chronic conditions like diabetes and ...
Vivani Medical, Inc. (NASDAQ: VANI) ("Vivani" or the "Company"), a clinical-stage biopharmaceutical company developing miniature ...
Crucially, the long-acting insulin was no worse than Tresiba when it came to rates of hypoglycaemia, when blood glucose levels dip too low, according to statistical comparisons between the drugs.
Health enthusiasts and biohackers are shifting toward plant-based, glucose-regulating supplements that focus on holistic wellness. Products like Sugar Defender are catching attention because they ...
A federal judge scolded the Trump administration on Tuesday for dragging its feet in complying with a Supreme Court order ...
6d
News-Medical.Net on MSNGLP-1 agonists may reshape the gut microbiomeResearch reveals GLP-1 receptor agonists influence gut microbiome, enhancing metabolic health and offering anti-inflammatory ...
4d
India Today on MSNWhen mom has diabetes, baby might too: The hidden risk few talk aboutNeonatal diabetes is a rare type of diabetes that appears in newborns, usually before six months of age. Genetic testing ...
There’s something beautifully simple about walking. No fancy equipment, no gym membership, just a pair of good shoes and a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results